Occupational hepatitis B remains a threat to healthcare workers (HCWs) worldwide, even with availability of an effective vaccine. Despite limited resources for public health, the Czech Republic instituted a mandatory vaccination program for HCWs in 1983. Annual incidence rates of acute hepatitis B were followed prospectively through 1995. Despite giving vaccine intradermally from 1983 to 1989 and intramuscularly as half dose from 1990 to 1995, rates of occupational hepatitis B decreased dramatically, from 177 cases per 100,000 workers in 1982 (before program initiated) to 17 cases per 100,000 in 1995. Among high-risk workers, the effect was even more dramatic (from 587 to 23 per 100,000). We conclude that strong public-health leadership led to control of occupational hepatitis B among HCWs in the Czech Republic, despite limited resources that precluded administering full-dose intramuscular vaccine for much of the program. Application of a similar program should be considered for other countries in regions that currently do not have a hepatitis B vaccination program.

National Institute of Public Health Prague Czech Republic

Zobrazit více v PubMed

Centers for Disease Control Protection against viral hepatitis: recommendations of the Immunization Practices Advisory Committee (ACIP) MMWR. 1990;39(RR-2):1–26. PubMed

Lewis TL, Alter HJ, Chalmers TC, Holland PV, Purcell RH, Alling DW, et al. A comparison of the frequency of hepatitis-B antigen and antibody in hospital and nonhospital personnel. N Engl J Med. 1973;289:647–651. PubMed

West DJ. The risk of hepatitis B infection among health professionals in the United States: a review. Am J Med Sci. 1984;287:26–33. PubMed

Osterholm MT, Garayalde SM. Clinical viral hepatitis B among Minnesota hospital personnel. JAMA. 1985;254:3207–3212. PubMed

Gibas A, Blewett Dr, Schoenfeld DA, Dienstag JL. Prevalence and incidence of viral hepatitis in health workers in the prehepatitis B vaccination era. Am J Epidemiol. 1992;136:603–610. PubMed

Sepkowitz KA. Occupationally acquired infections in health care workers, part II. Ann Intern Med. 1996;125:917–928. PubMed

Occupational exposure to bloodborne pathogens—OSHA: final rule. Fed Regist. 1991;56:64004–64182. PubMed

Shapiro CN. Occupational risk of infection with hepatitis B and hepatitis C virus. Surg Clin North Am. 1995;75:1047–1056. PubMed

Agerton TB, Mahoney FJ, Polish LB, Shapiro CN. Impact of the Bloodborne Pathogens Standard on vaccination of healthcare workers with hepatitis B vaccine. Infect Control Hosp Epidemiol. 1995;16:287–291. PubMed

Mahoney FJ, Stewart K, Hu H, Coleman P, Alter MJ. Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States. Arch Intern Med. 1997;157:2601–2605. PubMed

Louther J, Rivera P, Villa N, Feldman J, DeHovitz JH, Sepkowitz KA. Hepatitis B vaccination program at a New York City hospital: seroprevalence, seroconversion, and declination. Am J Infect Control. 1998;26:423–327. PubMed

Opatrný K, Farník J, Jindra J, Valenta J, Janda J, Petera V, et al. Virová hepatitis na hemodialyzaðním stredisku. Prakt Lék. 1978;58:753–756.

Markvart K, Lobkovic F, Vlasimská H, Pecenková I. Antibodies against the superficial component of hepatitis B virus of health care workers. Cesk Epidemiol Mikrobiol Imunol. 1978;27:327–334. Czech. PubMed

Farník J, Topolcan O, Karlícek V, Honzikova J, Mlada L, Beranova I, et al. HBS antigen and antibodies in health care workers. Cas Lék Ces. 1982;121:343–346. Czech. PubMed

Seycková J, Helcl J, Walter G. Prevalence of viral hepatitis among the hospital staff in CST between 1980 and 1982. J Hyg Epid (Praha) 1984;28:267–278. PubMed

Centers for Disease Control and Prevention Inadequate immune response among public safety workers receiving intradermal vaccination against hepatitis B—United States, 1990-1991. MMWR. 1991;40:569–572. PubMed

Lanphear BP, Linnemann CC, Cannon CG, DeRonde MM. Decline of clinical hepatitis B in workers at a general hospital: relation to increasing vaccine-induced immunity. Clin Infect Dis. 1993;16:10–14. PubMed

Alter MJ, Hadler SC, Margolis HS, Alexander WJ, Hu PY, Judson FN, et al. The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA. 1990;263:1218–1222. PubMed

Sikorska K, Laniec M, Buraczewska A, Hlebowicz M, Keller A, Majewska K. Iatrogenic hepatitis B, non-A non-B, and C virus infections acquired in health service institutions of the Gdansk province in 1986-1995. Przegl Epidemiol. 1997;51:229–237. Polish. PubMed

Narendranathan M, Philip M. Reusable needles—a major risk factor for acute virus B hepatitis. Trop Doct. 1993;23:64–66. PubMed

Epidemiology of hepatitis B and C among risk groups in Czechia